Institutional investors purchased a net $13.5 million shares of PRVB during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 45.52% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SESSA CAPITAL IM LP Bought 8.9 Million shares of Provention Bio Inc
ADAGE CAPITAL MANAGEMENT LP Bought 4.4 Million shares of Provention Bio Inc
MIRAE ASSET GLOBAL INVESTMENTS C... Sold 124.00 shares of Provention Bio Inc